基因素修饰剂KAT2A在微卫星稳定性结直肠癌中具有选择性标
Vida Kufrin1,2, Annika Seiler1,2, Silke Brilloff1,2
1Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Cell death and differentiation
|March 27, 2025
概括
氨酸乙转移酶2A (KAT2A) 对具有差异化表型的结直肠癌 (CRC) 的一个子集至关重要. 在这些癌症中减少KAT2A会减少生长并促进分化,这表明KAT2A是潜在的治疗点.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 氨酸乙转移酶2A (KAT2A) 与表观遗传基因调节和癌症进展有关.
- 增加KAT2A表达与结直肠癌 (CRC) 中的侵略性表型相关.
研究的目的:
- 研究CRC中KAT2A依赖的分子机制.
- 评估KAT2A耗尽对CRC细胞行为和瘤生长的影响.
主要方法:
- 在CRC细胞系中对CRISPR-Cas9查,基因组学,转录组学和乙化模式的综合分析.
- 在细胞系和3D球形培养中使用CRISPR干扰进行KAT2A敲击.
- 在患者衍生异种移植小鼠模型中的体内评估.
主要成果:
- 在CRC中KAT2A的依赖性与微卫星稳定性,低突变负担和差异化特征有关,无论KAT2A的表达水平如何.
- 依赖KAT2A的细胞表现出增强的基因表达和H3K27ac标记在肠细胞分化位置.
- 失去KAT2A会降低CRC细胞的生长和活力,降低基因增殖/干细胞的调控,并诱导分化标志物.
结论:
- 具有差异化特征的CRC的一个独特子集依赖于KAT2A.
- 抑制KAT2A阻碍了瘤的进展,并诱导了这些特定的CRC亚型的分化.
- 现在,KAT2A已经成为一组结直肠癌的潜在治疗标.
相关概念视频
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Destabilization of Microtubules
2.5K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.5K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K


